TSO3's new STERIZONE VP4 Sterilizer to be showcased at AORN Surgical Conference & Expo 2015

TSO₃ Inc. (TSX: TOS) ("TSO3" or the "Corporation") an innovator in sterilization technology for medical devices in healthcare settings, announced today that it will showcase its new STERIZONE^® VP4 Sterilizer at the AORN Surgical Conference & Expo 2015, held in Denver, Colorado from March 7 to 11, 2015. This annual convention of AORN (the Association of periOperative Registered Nurses) brings together approximately 6,000 registrants and is the largest U.S. nursing convention of stakeholders in the performance, efficacy and efficiency of low-temperature sterilization processes.

"While negotiations aimed at securing strong territory sales and service coverage continue, participation in a prominent American exhibition marks the launch of our market awareness and sales activities for our newly cleared STERIZONE^® VP4 Sterilizer," stated R.M. (Ric) Rumble, President and CEO of TSO₃. "We expect to meet with key decision-makers and influencers of the hospitals' sterilization processes, and demonstrate the superior claims of our technology."

TSO₃ will be showcasing its STERIZONE^® VP4 Technology at booth #536. Also, during the exhibit the Company has arranged a number of meetings with designers and manufacturers of medical equipment in order to demonstrate the strength of the technology compatibility and efficacy claims.

SOURCE TSO3 Inc.